Net Loss of Sun Pharma Advanced Research Company reported to Rs 107.33 crore in the quarter ended September 2024 as against net loss of Rs 86.42 crore during the previous quarter ended September 2023. Sales declined 39.28% to Rs 12.86 crore in the quarter ended September 2024 as against Rs 21.18 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 12.86 | 21.18 | -39 |
| OPM % | -800.23 | -431.87 | - |
| PBDT | -104.01 | -83.24 | -25 |
| PBT | -107.17 | -86.42 | -24 |
| NP | -107.33 | -86.42 | -24 |